Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(3)

Detailed Status

unknown3

Completed1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed120%

unknown360%

enrolling_by_invitation120%

Recent Activity

0 active trials

Showing 5 of 5

enrolling_by_invitationnot_applicable

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

NCT04847726

unknownnot_applicable

Evaluation of Hepatic Fibrosis on Multiparametric MRI

NCT03085342

Clinical Trials (5)

Showing 5 of 5 trials

NCT03176797Not Applicable

Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI

Enrolling By Invitation

NCT05182099Not Applicable

High Resolution HBA-MRI Using Deep Learning Reconstruction

Unknown

NCT03868397Not Applicable

Preoperative Portal and Splanchnic Flow Measurement Using MRI

Unknown

NCT04847726Not Applicable

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

Completed

NCT03085342Not Applicable

Evaluation of Hepatic Fibrosis on Multiparametric MRI

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 5